Nature Communications (Jul 2023)

SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma

  • Connor J. Hughes,
  • Kaiah M. Fields,
  • Etienne P. Danis,
  • Jessica Y. Hsu,
  • Deepika Neelakantan,
  • Melanie Y. Vincent,
  • Annika L. Gustafson,
  • Michael J. Oliphant,
  • Varsha Sreekanth,
  • Vadym Zaberezhnyy,
  • James C. Costello,
  • Paul Jedlicka,
  • Heide L. Ford

DOI
https://doi.org/10.1038/s41467-023-39945-w
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Ewing sarcoma (ES), which is characterized by the presence of oncogenic fusion proteins such as EWS/FLI1, is an aggressive pediatric malignancy with a high rate of early dissemination and poor outcome after distant spread. Here we demonstrate that the SIX1 homeoprotein, which enhances metastasis in most tumor types, suppresses ES metastasis by co-regulating EWS/FLI1 target genes. Like EWS/FLI1, SIX1 promotes cell growth/transformation, yet dramatically inhibits migration and invasion, as well as metastasis in vivo. We show that EWS/FLI1 promotes SIX1 protein expression, and that the two proteins share genome-wide binding profiles and transcriptional regulatory targets, including many metastasis-associated genes such as integrins, which they co-regulate. We further show that SIX1 downregulation of integrins is critical to its ability to inhibit invasion, a key characteristic of metastatic cells. These data demonstrate an unexpected anti-metastatic function for SIX1, through coordinate gene regulation with the key oncoprotein in ES, EWS/FLI1.